We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.55%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.06T
AUM Growth
-$16.9B
Cap. Flow
-$16.2B
Cap. Flow %
-1.53%
Top 10 Hldgs %
26.1%
Holding
3,048
New
131
Increased
1,029
Reduced
1,524
Closed
112

Top Buys

Rank Stock Value
1
XYZ
Block Inc
XYZ
+$2.39B
2
CVNA icon
Carvana
CVNA
+$1.82B
3
MSFT icon
Microsoft
MSFT
+$1.5B
4
DIS icon
Walt Disney
DIS
+$1.25B
5
SPOT icon
Spotify
SPOT
+$1.05B

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$2.65B
2
INTU icon
Intuit
INTU
+$2.08B
3
MTCH icon
Match Group
MTCH
+$1.87B
4
CRM icon
Salesforce
CRM
+$1.76B
5
META icon
Meta Platforms (Facebook)
META
+$1.61B

Sector Composition

Rank Sector Weight
1 Technology 25.08%
2 Healthcare 16.24%
3 Consumer Discretionary 15.33%
4 Communication Services 13.82%
5 Financials 12.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIL
2876
DELISTED
Hill International, Inc. Common Stock
HIL
$69K ﹤0.01%
33,200
HOFV
2877
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$67K ﹤0.01%
1,157
-14
-1% -$938
DFTX
2878
Definium Therapeutics
DFTX
$5.9B
$67K ﹤0.01%
1,919
+66
+4% +$2.85K
LTRX icon
2879
Lantronix
LTRX
$273M
$65K ﹤0.01%
11,200
WORX
2880
DELISTED
SCWORX CORP NEW
WORX
$65K ﹤0.01%
+134
New +$74.5K
RNAC icon
2881
Cartesian Therapeutics
RNAC
$267M
$64K ﹤0.01%
512
+25
+5% +$3.02K
PAYS icon
2882
Paysign
PAYS
$726M
$63K ﹤0.01%
23,500
-10,000
-30% -$26.8K
HGEN
2883
DELISTED
HUMANIGEN, INC.
HGEN
$63K ﹤0.01%
10,621
-100
-0.9% -$1.41K
TLPH icon
2884
Talphera
TLPH
$62.8M
$62K ﹤0.01%
3,020
-1,765
-37% -$40.4K
EMAN
2885
DELISTED
eMagin Corporation
EMAN
$62K ﹤0.01%
27,300
+8,800
+48% +$23.3K
ACGN
2886
DELISTED
Aceragen Inc
ACGN
$62K ﹤0.01%
3,556
KG
2887
Kestrel Group
KG
$63.5M
$56K ﹤0.01%
891
-30
-3% -$1.96K
BRN icon
2888
Barnwell Industries
BRN
$13.9M
$55K ﹤0.01%
18,200
KLXE icon
2889
KLX Energy Services
KLXE
$36M
$52K ﹤0.01%
10,900
OGEN icon
2890
Oragenics
OGEN
$2.39M
$51K ﹤0.01%
+44
New +$53.1K
RMO
2891
DELISTED
Romeo Power, Inc.
RMO
$51K ﹤0.01%
+10,336
New +$61.8K
HLX icon
2892
Helix Energy Solutions
HLX
$1.5B
$47K ﹤0.01%
12,018
BOAC.WS
2893
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$47K ﹤0.01%
46,500
-2,500
-5% -$2.79K
POL
2894
DELISTED
Polished.com Inc.
POL
$46K ﹤0.01%
+290
New +$43.7K
CARM
2895
DELISTED
Carisma Therapeutics
CARM
$44K ﹤0.01%
2,798
LGMK
2896
DELISTED
LogicMark
LGMK
$44K ﹤0.01%
21
+14
+200% +$47.6K
VSTM icon
2897
Verastem
VSTM
$616M
$44K ﹤0.01%
1,193
+41
+4% +$1.51K
AGRX
2898
DELISTED
Agile Therapeutics
AGRX
$41K ﹤0.01%
21
-20
-49% -$45.3K
CTXR icon
2899
Citius Pharmaceuticals
CTXR
$19.9M
$40K ﹤0.01%
784
+24
+3% +$1.2K
INUV icon
2900
Inuvo
INUV
$14.6M
$40K ﹤0.01%
5,660

Similar funds

T. Rowe Price Associates's Q3 2021 Portfolio in Review

As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
  • T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
  • T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
  • T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
  • T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
  • T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.

Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.